NPPA lens on five pharma companies for Hepatitis C drug overcharge

NPPA has sent show-cause notices to these companies alleging overcharging for the combination drug used to treat the potentially fatal Hepatitis C virus that harms the liver.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news